The tolerable upper intake level (UL) for adults is 3,500 mg/day
Mechanistic Studies in Neurodegeneration: Further elucidation of GLP-1RAs neuroprotective mechanisms (eg, anti-inflammatory effects, amelioration of cerebral insulin resistance) is warranted, along with evaluation of the neuropsychiatric potential of GLP-1/GIP dual agonists
NICE has similarly recommended digital programmes from six other providers: Ovivo, Roczen, Second Nature, CheqUp, Gro Health W8 Buddy, and Juniper
however, these findings need to be further validated in randomised controlled trials, lead study author Markku Lhteenvuo, MD, PhD, of the University of Eastern Finland and the Niuvanniemi Hospital, in a statement